The Academy of Managed Care Pharmacy (AMCP) has accepted an abstract co-authored by CDA for presentation at their Annual Meeting.
- Budget impact/cost-offset model comparing once-daily extended-release vs twice-daily immediate-release ruxolitinib in myelofibrosis: A US payer perspective
The CDA team will also be in attendance at AMCP Annual – Exhibit Booth #1027
The AMCP Annual Meeting will be held in Nashville, TN, April 13-16, 2026.
